Delayed Norfentanyl Clearance During Pregnancy.

Obstet Gynecol

Departments of Obstetrics and Gynecology and Psychiatry, Boston University School of Medicine, and the Department of Obstetrics and Gynecology, Boston Medical Center, Boston, Massachusetts.

Published: November 2020

Background: We report a case of delayed norfentanyl clearance in a 33-year-old pregnant woman. Norfentanyl is the major metabolite of fentanyl.

Case: A multigravid woman with opioid use disorder presented at 7 weeks of gestation for treatment. Despite opioid abstinence, her urine was positive for norfentanyl on 10 distinct gas chromatography-mass spectrometry urine screens. The results demonstrated a steady decrease of norfentanyl over the course of 70 days after her last fentanyl usage, far exceeding expected rates of fentanyl clearance.

Conclusion: This case highlights the importance of acknowledging pregnancy, genetic, or medication-induced changes to fentanyl pharmacokinetics when interpreting urine tests, especially given the potential sequelae of a false-positive urine test result.

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000004106DOI Listing

Publication Analysis

Top Keywords

delayed norfentanyl
8
norfentanyl clearance
8
clearance pregnancy
4
pregnancy background
4
background report
4
report case
4
case delayed
4
norfentanyl
4
clearance 33-year-old
4
33-year-old pregnant
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!